These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 25663455)

  • 1. CRISPR genome engineering and viral gene delivery: a case of mutual attraction.
    Schmidt F; Grimm D
    Biotechnol J; 2015 Feb; 10(2):258-72. PubMed ID: 25663455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Viruses as Genome Editing Devices.
    Chen X; Gonçalves MA
    Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.
    Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A
    Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest development in viral vectors for gene therapy.
    Lundstrom K
    Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
    Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
    Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.
    Kaulich M; Dowdy SF
    Nucleic Acid Ther; 2015 Dec; 25(6):287-96. PubMed ID: 26540648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and specificity of TRV-mediated gene editing in plants.
    Ali Z; Abul-Faraj A; Piatek M; Mahfouz MM
    Plant Signal Behav; 2015; 10(10):e1044191. PubMed ID: 26039254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Delivery Systems for CRISPR.
    Xu CL; Ruan MZC; Mahajan VB; Tsang SH
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30621179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
    Gasiunas G; Siksnys V
    Trends Microbiol; 2013 Nov; 21(11):562-7. PubMed ID: 24095303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.
    Barrangou R; Birmingham A; Wiemann S; Beijersbergen RL; Hornung V; Smith Av
    Nucleic Acids Res; 2015 Apr; 43(7):3407-19. PubMed ID: 25800748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of eGFP and Cre knockin rats by CRISPR/Cas9.
    Ma Y; Ma J; Zhang X; Chen W; Yu L; Lu Y; Bai L; Shen B; Huang X; Zhang L
    FEBS J; 2014 Sep; 281(17):3779-90. PubMed ID: 25039742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology.
    Schmelas C; Grimm D
    Biotechnol J; 2018 Sep; 13(9):e1700432. PubMed ID: 29316283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.